Oribamide (Hydroxycarbamide)

Hydroxycarbamide, the active ingredient in Oribamide, is a drug class presented as a strength/form for oral use. It treats certain blood‑related disorders and is used under medical supervision.

GNH USA supplies Oribamide as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Oribamide is employed in the management of hematologic conditions where abnormal cell proliferation is a concern. - Chronic myeloid leukemia: helps control disease progression by reducing leukemic cell counts. - Polycythemia vera: lowers elevated red blood cell mass, decreasing risk of thrombosis. - Sickle‑cell disease: reduces frequency of painful vaso‑occlusive crises.

Adverse reactions to hydroxycarbamide can vary in frequency and severity.

Common Side Effects: - Nausea and vomiting - Loss of appetite - Mild skin discoloration (hyperpigmentation) - Low platelet count ( thrombocytopen ). - Fatigue .

Serious or Rare Side Effects: - Severe neutropenia

t   - Acute     t     \n-      -  g . -   

When  g   ewline   ewline   ewline